Literature DB >> 9284897

Serum creatine, creatinine, and other guanidino compounds in patients with thyroid dysfunction.

J Verhelst1, J Berwaerts, B Marescau, R Abs, H Neels, C Mahler, P P De Deyn.   

Abstract

Serum levels of creatine (CT), creatinine (CTN), urea, guanidinosuccinic acid (GSA), guanidinoacetic acid (GAA), guanidine (G), arginine (Arg), homoarginine (Harg), argininic acid (ArgA), and alpha-keto-delta-guanidinovaleric acid (alpha-K-delta-GVA) were measured in 54 patients with hyperthyroidism, 56 with subclinical hyperthyroidism, 28 with subclinical hypothyroidism, and 51 with hypothyroidism compared with 62 euthyroid controls. In agreement with previous reports, serum CT increased (+35%) and CTN decreased (-17.6%) in hyperthyroidism as compared with normal thyroid function, whereas the opposite was seen in hypothyroidism (-17.7% and +11%, P < .0001). Original findings from this study are a highly significant decrease in GSA (-41.7%) and GAA (-36.8%) in hyperthyroidism and an increase in GSA (+36%) in hypothyroidism (P < .0001). In addition, a slight decrease in hyperthyroidism and hypothyroidism was noted for Arg (-6.2% and -13.2%, P = .001) and Harg (-14.8% and -18.1%, P = .05). By contrast, no significant change was seen in levels of urea, G, ArgA, and alpha-K-delta-GVA. No major differences were found for any of the compounds between subclinical hypothyroidism, euthyroidism, and subclinical hyperthyroidism. There was a highly significant positive linear correlation between urea and GSA levels in hyperthyroidism, euthyroidism, and hypothyroidism (r = .68, r = .77, and r = .75, P < .0001), taking into account that for the same increase in urea, GSA increased threefold more in hypothyroid versus hyperthyroid patients. In conclusion, apart from CT and CTN, significant changes can be found in serum levels of GSA, GAA, Arg, and Harg in patients with thyroid dysfunction. Subclinical thyroid dysfunction does not seem to induce changes in serum levels of guanidino compounds. Decreased serum GSA and GAA levels might be an additional indicator of hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284897     DOI: 10.1016/s0026-0495(97)90279-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  15 in total

1.  Regulation of expression of antioxidant enzymes by vitamin E and curcumin in L-thyroxine-induced oxidative stress in rat renal cortex.

Authors:  Srikanta Jena; Gagan Bihari Nityananda Chainy
Journal:  Mol Biol Rep       Date:  2010-06-24       Impact factor: 2.316

2.  Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients.

Authors:  Yuji Hataya; Shuta Igarashi; Takafumi Yamashita; Yasato Komatsu
Journal:  Clin Exp Nephrol       Date:  2012-11-17       Impact factor: 2.801

3.  Hypothyroidism mimicking chronic renal failure in reflux nephropathy.

Authors:  M Bald; B P Hauffa; A M Wingen
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

4.  Thyroid Dysfunction and Kidney Dysfunction.

Authors:  Intisar Al Fahdi; Issa Al Salmi; Fatma Al Rahbi; Faisal Shaheen; Suad Hannawi
Journal:  Oman Med J       Date:  2022-05-31

5.  Effects in vitro of guanidinoacetate on adenine nucleotide hydrolysis and acetylcholinesterase activity in tissues from adult rats.

Authors:  Roselia Maria Spanevello; Angela Terezinha de Souza Wyse; Cinthia Melazzo Mazzanti; Roberta Schmatz; Naiara Stefanello; Jamile Fabbrin Gonçalves; Margarete Bagatini; Vanessa Battisti; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Journal:  Neurochem Res       Date:  2008-02-07       Impact factor: 3.996

6.  Preservation of renal function by thyroid hormone replacement in elderly persons with subclinical hypothyroidism.

Authors:  Yu Lu; Hong Guo; Dongmei Liu; Zhen Zhao
Journal:  Arch Med Sci       Date:  2016-07-01       Impact factor: 3.318

7.  Serum Spot 14 concentration is negatively associated with thyroid-stimulating hormone level.

Authors:  Yen-Ting Chen; Fen-Yu Tseng; Pei-Lung Chen; Yu-Chao Chi; Der-Sheng Han; Wei-Shiung Yang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

8.  Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis model.

Authors:  Maik Pietzner; Beatrice Engelmann; Tim Kacprowski; Janine Golchert; Anna-Luise Dirk; Elke Hammer; K Alexander Iwen; Matthias Nauck; Henri Wallaschofski; Dagmar Führer; Thomas F Münte; Nele Friedrich; Uwe Völker; Georg Homuth; Georg Brabant
Journal:  BMC Med       Date:  2017-01-09       Impact factor: 8.775

9.  Congenital hypothyroidism presenting with reversible renal impairment: an under-recognised problem?

Authors:  Leïla Essaddam; Asma Ben Mansour; Nada Missaoui; Rahma Guedri; Nadia Mattoussi; Zohra Fitouri; Saayda Ben Becher
Journal:  J Diabetes Metab Disord       Date:  2019-08-14

10.  Serum Levels of Follistatin Are Positively Associated With Serum-Free Thyroxine Levels in Patients With Hyperthyroidism or Euthyroidism.

Authors:  Fen-Yu Tseng; Yen-Ting Chen; Yu-Chao Chi; Pei-Lung Chen; Wei-Shiung Yang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.